Article

Integration of pharmacogenomics and radiation genomics in targeted radionuclide therapy

2026-08-08

Abstract excerpt

Targeted radionuclide therapy (TRT) is a rapidly growing therapeutic modality designed to deliver highly localised cytotoxic radiation to tumour cells, while minimising exposure to surrounding healthy tissues. This approach has been demonstrated to be beneficial in prolonging progression-free survival and/or overall survival in thyroid carcinoma, neuroendocrine tumours and prostate carcinoma. However, treatment ef...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36d5ae5b-53fa-5096-9ac7-c3b79a3e00ca
DOI: 10.1016/j.eanmi.2026.100293

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integration of pharmacogenomics and radiation genomics in targeted radionuclide therapyDOI 10.1016/j.eanmi.2026.100293Read

Radiogenomics: the search for genetic predictors of radiotherapy response.Semantic proximity Read

Radiogenomics in the Era of Advanced RadiotherapySemantic proximity Read

Genetics and genomics of radiotherapy toxicity: towards predictionSemantic proximity Read

Radiogenomics - current status, challenges and future directions.Semantic proximity Read

Radiation biology and oncology in the genomic eraSemantic proximity Read

Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.Semantic proximity Read

Radiogenomics: towards a personalized radiation oncology.Semantic proximity Read

Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.Semantic proximity Read

Radiotherapy-Induced Malignancies: Review of Clinical Features, Pathobiology, and Evolving Approaches for Mitigating RiskSemantic proximity Read

Tailoring cancer radiotherapy through genotyping, how close are we?Semantic proximity Read

Radiogenomics: a key component of precision cancer medicine.Semantic proximity Read

Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects.Semantic proximity Read